RA Capital Healthcare Fund LP, Director, 10% Owner at Tyra Biosciences, Inc. (TYRA), bought 2,441,362 shares at $16.25 ($39.7M) on 2024-11-08, disclosed to the SEC on 2024-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.25 | 1,220,681 | $19.8M | 50.0% |
| 2 | $16.25 | 1,220,681 | $19.8M | 50.0% |
| Total | $16.25 avg | 2,441,362 | $39.7M | 100% |
| Filing → |
| FULC | SELL | 2025-12-10 | $116.8M | — | Filing → |
| PEPG | BUY | 2025-09-30 | $30.0M | — | Filing → |
| TYRA | BUY | 2025-06-11 | $3.8M | — | Filing → |